Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Nantahala Capital Management

Tracked across 2 events · 13 articles · First seen Apr 14, 2026 · Last active Aug 10, 2026

Sentiment
15
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 20
Business
Femasys Inc., a biomedical company developing fertility and non-surgical permanent birth control solutions, announced on August 7, 2026 that it entered into a securities purchase agreement for a $30 million private placement with accredited investors.…
Impact: Nantahala Capital Management led the private placement as the new institutional investor, demonstrating confidence in Femasys' strategy and technologies.
Aug 07, 2026 · 6 articles
4 10
Business
Impact: Nantahala Capital Management is one of the new investors participating in the $350 million private placement financing for the combined Galera Therapeutics and Obsidian Therapeutics, Inc. entity.
Apr 14, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Nantahala Capital Management live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.